Elena del Olmo - Publications

Affiliations: 
Faes Ltd, Kingston upon Thames, England, United Kingdom 

21 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Castro E, Díaz A, Rodriguez-Gaztelumendi A, Del Olmo E, Pazos A. WAY100635 prevents the changes induced by fluoxetine upon the 5-HT1A receptor functionality. Neuropharmacology. 55: 1391-6. PMID 18809415 DOI: 10.1016/j.neuropharm.2008.08.038  0.628
2008 Sáiz J, Pazos A, Del Olmo E, Sáiz V, Sánchez A. Yohimbine-induced alterations in alpha(2)-adrenoceptors in kidney regions of the spontaneously hypertensive rats: an autoradiographic analysis. Pharmacological Reports : Pr. 60: 391-8. PMID 18622064  0.454
2006 Zazpe A, Artaiz I, Innerárity A, Del Olmo E, Castro E, Labeaga L, Pazos A, Orjales A. In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties. Neuropharmacology. 51: 129-40. PMID 16643965 DOI: 10.1016/j.neuropharm.2006.03.008  0.516
2006 Ruiz de Azúa I, del Olmo E, Pazos A, Sallés J. Transmembrane signaling through phospholipase C-beta in the developing human prefrontal cortex. Journal of Neuroscience Research. 84: 13-26. PMID 16615043 DOI: 10.1002/jnr.20858  0.546
2005 Artaiz I, Zazpe A, Innerárity A, Del Olmo E, Díaz A, Ruiz-Ortega JA, Castro E, Pena R, Labeaga L, Pazos A, Orjales A. Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties. Psychopharmacology. 182: 400-13. PMID 16032410 DOI: 10.1007/s00213-005-0087-3  0.685
2003 Mato S, Del Olmo E, Pazos A. Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. The European Journal of Neuroscience. 17: 1747-54. PMID 12752773 DOI: 10.1046/J.1460-9568.2003.02599.X  0.741
2003 Castro M, Diaz A, del Olmo E, Pazos A. Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain. Neuropharmacology. 44: 93-101. PMID 12559126 DOI: 10.1016/S0028-3908(02)00340-4  0.669
2001 del Olmo E, Pazos A. Aminergic receptors during the development of the human brain: the contribution of in vitro imaging techniques. Journal of Chemical Neuroanatomy. 22: 101-14. PMID 11470558 DOI: 10.1016/S0891-0618(01)00097-7  0.651
1998 Pazos A, Castro ME, del Olmo E, Romón T, del Arco C. Autoradiographic characterization, anatomical distribution, and developmental pattern of a new 5-HT site in human brain. Annals of the New York Academy of Sciences. 861: 262. PMID 9928279 DOI: 10.1111/j.1749-6632.1998.tb10213.x  0.532
1998 del Olmo E, López-Giménez JF, Vilaró MT, Mengod G, Palacios JM, Pazos A. Early localization of mRNA coding for 5-HT1A receptors in human brain during development. Brain Research. Molecular Brain Research. 60: 123-6. PMID 9748536 DOI: 10.1016/S0169-328X(98)00149-1  0.67
1997 Castro ME, Romón T, Castillo MJ, del Olmo E, Pazos A, del Arco C. Identification and characterization of a new serotonergic recognition site with high affinity for 5-carboxamidotryptamine in mammalian brain. Journal of Neurochemistry. 69: 2123-31. PMID 9349558 DOI: 10.1046/J.1471-4159.1997.69052123.X  0.599
1997 Castro ME, Pascual J, Romón T, del Arco C, del Olmo E, Pazos A. Differential distribution of [3H]sumatriptan binding sites (5-HT1B, 5-HT1D and 5-HT1F receptors) in human brain: focus on brainstem and spinal cord. Neuropharmacology. 36: 535-42. PMID 9225278 DOI: 10.1016/S0028-3908(97)00061-0  0.654
1996 Pascual J, del Arco C, Romón T, del Olmo E, Castro E, Pazos A. Autoradiographic distribution of [3H]sumatriptan-binding sites in post-mortem human brain. Cephalalgia : An International Journal of Headache. 16: 317-22. PMID 8869766 DOI: 10.1046/J.1468-2982.1996.1605317.X  0.655
1996 Pascual J, Del Arco C, Romón T, Del Olmo E, Pazos A. [3H]Sumatriptan binding sites in human brain: regional-dependent labelling of 5-HT1D and 5-HT1F receptors. European Journal of Pharmacology. 295: 271-4. PMID 8720594 DOI: 10.1016/0014-2999(95)00748-2  0.649
1996 del Olmo E, del Arco C, Díaz A, Pascual J, Mengod G, Palacios JM, Pazos A. Ontogenetic development of 5-HT1D receptors in human brain: an autoradiographic study. The European Journal of Neuroscience. 8: 53-60. PMID 8713449 DOI: 10.1111/J.1460-9568.1996.Tb01166.X  0.741
1994 del Olmo E, Díaz A, Guirao-Piñeyro M, del Arco C, Pascual J, Pazos A. Transient localization of 5-HT1A receptors in human cerebellum during development. Neuroscience Letters. 166: 149-52. PMID 8177491 DOI: 10.1016/0304-3940(94)90472-3  0.67
1994 Pascual J, Figols J, Grijalba B, González AM, del Olmo E, Berciano J, Pazos A. Changes in aminergic receptors in a PSP postmortem brain: correlation with pathological findings. Journal of Neural Transmission. Supplementum. 42: 247-60. PMID 7964690 DOI: 10.1007/978-3-7091-6641-3_19  0.734
1992 Pascual J, Berciano J, Grijalba B, del Olmo E, González AM, Figols J, Pazos A. Dopamine D1 and D2 receptors in progressive supranuclear palsy: an autoradiographic study. Annals of Neurology. 32: 703-7. PMID 1449252 DOI: 10.1002/Ana.410320516  0.716
1992 Lafarga M, Berciano MT, Del Olmo E, Andres MA, Pazos A. Osmotic stimulation induces changes in the expression of beta-adrenergic receptors and nuclear volume of astrocytes in supraoptic nucleus of the rat. Brain Research. 588: 311-6. PMID 1327410 DOI: 10.1016/0006-8993(92)91592-3  0.467
1991 Pascual J, Pazos A, del Olmo E, Figols J, Leno C, Berciano J. Presynaptic parkinsonism in olivopontocerebellar atrophy: clinical, pathological, and neurochemical evidence. Annals of Neurology. 30: 425-8. PMID 1952831 DOI: 10.1002/ana.410300318  0.518
1991 Pascual J, del Arco C, González AM, Díaz A, del Olmo E, Pazos A. Regionally specific age-dependent decline in alpha 2-adrenoceptors: an autoradiographic study in human brain. Neuroscience Letters. 133: 279-83. PMID 1687760 DOI: 10.1016/0304-3940(91)90588-K  0.675
Show low-probability matches.